戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 nt immune cells with versatile functions for therapeutic purpose.
2 or preparation of phytochemical essences for therapeutic purpose.
3 delivery of non-viral genes into the CNS for therapeutic purpose.
4 ther application in pathogens diagnostic and therapeutic purpose.
5 ding of ABMR and be useful for diagnostic or therapeutic purposes.
6 etitive RNAs are required for diagnostic and therapeutic purposes.
7  for basic research in life sciences and for therapeutic purposes.
8 eting the receptor of choice for research or therapeutic purposes.
9 for siRNA delivery that can be developed for therapeutic purposes.
10  stem cells from normal tissue for potential therapeutic purposes.
11 cin as well as Skp2 silencing strategies for therapeutic purposes.
12 ptors and could potentially be exploited for therapeutic purposes.
13 euromodulation of specific brain regions for therapeutic purposes.
14 CRISPR-Cas9 in vitro and in vivo for various therapeutic purposes.
15 aggregatory low-molecular mass molecules for therapeutic purposes.
16 al networks ex vivo for disease modeling and therapeutic purposes.
17 t might be exploited for both prognostic and therapeutic purposes.
18 functional plasticity might be exploited for therapeutic purposes.
19 iple sclerosis, which could be exploited for therapeutic purposes.
20 nce of targeting the marrow niche in MPN for therapeutic purposes.
21 oligonucleotides on demand, for research and therapeutic purposes.
22 , in order to alter muscle contractility for therapeutic purposes.
23 n produced and evaluated (pre)clinically for therapeutic purposes.
24  poorly defined for genetic manipulation and therapeutic purposes.
25  to disrupt the G alpha(i)-GIV interface for therapeutic purposes.
26  means to screen for inhibitors of RNAPs for therapeutic purposes.
27 der to exploit this endogenous mechanism for therapeutic purposes.
28 ategies aimed at modulating M3R activity for therapeutic purposes.
29  to optimize the release of either agent for therapeutic purposes.
30 rts to develop pathway antagonists for human therapeutic purposes.
31 e potential of manipulating this pathway for therapeutic purposes.
32 yed as veterinary drugs for prophylactic and therapeutic purposes.
33 ting Tregs and Tconvs can be manipulated for therapeutic purposes.
34  natural biological circuits for research or therapeutic purposes.
35 ential target to promote insulin release for therapeutic purposes.
36 ently large numbers of suppressive Tregs for therapeutic purposes.
37 arcinogenesis, but may also be exploited for therapeutic purposes.
38 sful manipulation of biological pathways for therapeutic purposes.
39 need be fully explored and might be used for therapeutic purposes.
40 lution, as well as the use of stem cells for therapeutic purposes.
41  production of less immunogenic proteins for therapeutic purposes.
42 ry few well-identified validated targets for therapeutic purposes.
43 sive prostate cancer for both prognostic and therapeutic purposes.
44 nd the generation of a whole "bio-tooth" for therapeutic purposes.
45 etitively, it is being developed for various therapeutic purposes.
46 unctions, and to exploit these molecules for therapeutic purposes.
47 y may facilitate expansion of HSC number for therapeutic purposes.
48 lt it will be to exploit cell plasticity for therapeutic purposes.
49 nd ultimately can be used for diagnostic and therapeutic purposes.
50 implications for diagnostic, prognostic, and therapeutic purposes.
51 h to modifying oligonucleotides intended for therapeutic purposes.
52 le genetic networks for biotechnological and therapeutic purposes.
53 in gliomas and how they may be exploited for therapeutic purposes.
54  of telomerase used to immortalize cells for therapeutic purposes.
55 f current attempts to target or use TAMs for therapeutic purposes.
56 oited to enhance cannabinergic signaling for therapeutic purposes.
57 nt of small-molecule inhibitors of Vps34 for therapeutic purposes.
58 ic progenitors from embryonic stem cells for therapeutic purposes.
59 he pharmacologic targeting of HIF-1alpha for therapeutic purposes.
60 erefore, these mouse Mabs cannot be used for therapeutic purposes.
61 CAM-1 interaction for biological studies and therapeutic purposes.
62  late-passage hESC lines may be unusable for therapeutic purposes.
63 manipulation of hematopoietic precursors for therapeutic purposes.
64 es have hampered the use of CD133+ cells for therapeutic purposes.
65 dation for exploitation of this approach for therapeutic purposes.
66 cult, but it is important for prognostic and therapeutic purposes.
67  markers that may be used for diagnostic and therapeutic purposes.
68  hypothesize that they will prove useful for therapeutic purposes.
69 f compounds as a stratagem to deliver CO for therapeutic purposes.
70 ity of differentiating among these genes for therapeutic purposes.
71 hinders the use of lasers for diagnostic and therapeutic purposes.
72 the mammary epithelium for both research and therapeutic purposes.
73 ell biology, virology, and gene delivery for therapeutic purposes.
74  be relevant to manipulation of NK cells for therapeutic purposes.
75 o study these ligases for basic research and therapeutic purposes.
76 ype that can be useful for diagnostic and/or therapeutic purposes.
77 ystem to be manipulated more effectively for therapeutic purposes.
78 anding the mechanisms of Tie2 activation for therapeutic purposes.
79 t functional properties for prophylactic and therapeutic purposes.
80 ne expression in vivo for imaging as well as therapeutic purposes.
81 in diverse cell types that may be useful for therapeutic purposes.
82  to interfere with microglial activation for therapeutic purposes.
83  regulating specific caspase-6 functions for therapeutic purposes.
84 in the development of chimeric receptors for therapeutic purposes.
85 ors that can be used for both diagnostic and therapeutic purposes.
86 loading of antigens onto dendritic cells for therapeutic purposes.
87 th of these can deliver anticancer cDNAs for therapeutic purposes.
88 nce our ability to manipulate stem cells for therapeutic purposes.
89  of NF-kappa B-dependent gene expression for therapeutic purposes.
90 te or inhibit the TLR4 signaling pathway for therapeutic purposes.
91  that this phenomenon might be exploited for therapeutic purposes.
92 loiting membrane compositional variation for therapeutic purposes.
93 fic peptide/MHC complexes for diagnostic and therapeutic purposes.
94 itis underwent vitrectomy for diagnostic and therapeutic purposes.
95 ventual deployment of lentivirus vectors for therapeutic purposes.
96 ady source of CCR6+ monocyte-derived DCs for therapeutic purposes.
97 AMs in the development of surrogate TCRs for therapeutic purposes.
98 e mechanisms is amenable to manipulation for therapeutic purposes.
99 manipulating the B7 costimulatory signal for therapeutic purposes.
100  a highly suitable target for diagnostic and therapeutic purposes.
101  of factor Xa with reversible inhibitors for therapeutic purposes.
102  tools in tumor targeting for diagnostic and therapeutic purposes.
103 d locally within selected target tissues for therapeutic purposes.
104  vitro and in vivo for both experimental and therapeutic purposes.
105 he induction of the formation of alveoli for therapeutic purposes.
106 nts in either soluble or cell-based TCRs for therapeutic purposes.
107  molecular tools to harness this pathway for therapeutic purposes.
108  cells and facilitate their exploitation for therapeutic purposes.
109 on the use of MSC are currently underway for therapeutic purposes.
110 s that might be exploited for diagnostic and therapeutic purposes.
111  5'-terminus is important for analytical and therapeutic purposes.
112 for manipulating live cells for research and therapeutic purposes.
113  potentially streamlining iCM production for therapeutic purposes.
114  Tconv might be regulated differentially for therapeutic purposes.
115 ystem have key implications for research and therapeutic purposes.
116 ion of probes for target exploration and for therapeutic purposes.
117  the reprogramming of metabolic pathways for therapeutic purposes.
118  subcellular structure could be targeted for therapeutic purposes.
119  antagonize CSC in human prostate cancer for therapeutic purposes.
120 nd cautions against targeting the enzyme for therapeutic purposes.
121 n Union, while prednisolone is permitted for therapeutic purposes.
122 erefore become an attractive target area for therapeutic purposes.
123 ology research towards promising utility for therapeutic purposes.
124 pain opens routes to exploit this system for therapeutic purposes.
125 lockade of vasopressin receptor subtypes for therapeutic purposes.
126 erefore appearing particularly promising for therapeutic purposes.
127 ent-dependent cytotoxicity, is desirable for therapeutic purposes.
128  of this disease vector for preventative and therapeutic purposes.
129 ic receptors that reprogram immune cells for therapeutic purposes.
130 regation inhibitors for biotechnological and therapeutic purposes.
131 ity of rational manipulation of immunity for therapeutic purposes.
132 ilencing and/or expressing a desired RNA for therapeutic purposes.
133 d TA as target candidates for diagnostic and therapeutic purposes.
134 hal interactions that could be exploited for therapeutic purposes.
135 t to study how V-ATPase can be modulated for therapeutic purposes.
136 tor, opening a possible drug design path for therapeutic purposes.
137 d how these mechanisms might be targeted for therapeutic purposes.
138 les for approaches to modify BMP9 levels for therapeutic purposes.
139 t in transplantation of human stem cells for therapeutic purposes.
140 lations of circulating cells for research or therapeutic purposes.
141 rch has focused on utilizing these cells for therapeutic purposes.
142 nstrated the suitability of using (47)Sc for therapeutic purposes.
143 ll transplantation (HSCT) for preventive and therapeutic purposes.
144 all-molecule agents for biotechnological and therapeutic purposes.
145 convenient pharmacological source of HNO for therapeutic purposes.
146 s and opportunities to manipulate miRNAs for therapeutic purposes.
147 thogenesis of CLL but could also be used for therapeutic purposes.
148 g novel-molecular targets for prognostic and therapeutic purposes.
149 ammation, that could be further targeted for therapeutic purposes.
150 y could prove useful for suppressing HGP for therapeutic purposes.
151 focus of efforts to manipulate cell fate for therapeutic purposes.
152 nvestigating potential targeting of HIFs for therapeutic purposes.
153  intracisternal administration of IL-1RA for therapeutic purposes.
154 ies to regenerate cardiovascular tissues for therapeutic purposes.
155 edirect the specificity of T lymphocytes for therapeutic purposes.
156  produce autologous differentiated cells for therapeutic purposes, a concept termed therapeutic cloni
157 tations associated with protein delivery for therapeutic purposes, a greater number of different deli
158 ers for diagnostic, prognostic, and targeted therapeutic purposes, although individual data sets may
159 ings may facilitate the use of hES cells for therapeutic purposes and as in vitro models of developme
160 biopreservation protocols for cells used for therapeutic purposes and for cellular biofluids.
161 e, such intermediates could be exploited for therapeutic purposes and may reflect a conserved state a
162 ting NKp30-mediated NK cell cytotoxicity for therapeutic purposes and provides proof of concept that
163                    To harness iNKT cells for therapeutic purposes and to understand their role in viv
164 ranial electrodes in the auditory cortex for therapeutic purposes, and measured high-frequency (50-15
165 ides an opportunity to modulate immunity for therapeutic purposes, and to monitor the immune response
166 er its use in iPSC for research and possible therapeutic purposes; and we will review its use in musc
167 ation and administration of 1311 anti-B1 for therapeutic purposes are reviewed.
168 g probiotics to our diet for prophylactic or therapeutic purposes, as well as better regulation of th
169 ve antagonist hybrids can be very useful for therapeutic purposes because they enable us to stably ac
170 readily generating affinity-enhanced TCR for therapeutic purposes but demonstrate that minimal change
171 amber implants were originally developed for therapeutic purposes but have been used recently for the
172 iversification will not only be relevant for therapeutic purposes but might also shed light on the di
173 e that this mechanism could be exploited for therapeutic purposes by targeting PTPN22 with PKC inhibi
174 toplasty differs markedly when performed for therapeutic purposes compared with visual rehabilitation
175 pt of introducing genes into human cells for therapeutic purposes developed nearly 50 years ago as di
176 g an exciting source of genetic material for therapeutic purposes due to its exceptional biocompatibi
177 obes for both diagnostic (e.g., imaging) and therapeutic purposes (e.g., drug delivery).
178 iscovery using a fragment-based approach for therapeutic purposes for SOD1 associated motor neuron di
179 importance is also extensively exploited for therapeutic purposes, for instance in the treatment of n
180  mutKIT at diagnosis for both prognostic and therapeutic purposes, given that activated KIT potential
181 major impediment to the use of iPS cells for therapeutic purposes has been the viral-based delivery o
182 o date, efforts to modulate miRNA levels for therapeutic purposes have been challenging to implement.
183                                          For therapeutic purposes, however, the bivalency of IgG and
184 fic ICAM-3-grabbing nonintegrin (L-SIGN) for therapeutic purposes in autoimmunity and infectious dise
185 ntibodies may prove useful for diagnostic or therapeutic purposes in cancer, infectious diseases, and
186 prognosis, and prevention of cancer, and for therapeutic purposes in defined situations.
187 sing neurostimulation techniques over S1 for therapeutic purposes in dystonic patients.
188 velopment of blocking anti-CD1d antibody for therapeutic purposes in humans.
189 great potential as targets for diagnosis and therapeutic purposes in infectious diseases, allergies,
190 cating that pharmacological manipulation for therapeutic purposes in intestinal inflammatory conditio
191  potential risk of complement inhibition for therapeutic purposes in pregnancy.
192 tor numbers in harnessing CD4(+) T cells for therapeutic purposes in such conditions.
193 ssification may be useful for diagnostic and therapeutic purposes in the clinical practice.
194  more than 60 y-as (131)I for diagnostic and therapeutic purposes in thyroid diseases.
195 esirability of increasing beta-cell mass for therapeutic purposes in type 2 diabetes.
196 thod has occurred for special diagnostic and therapeutic purposes, including balloon valvuloplasties
197 possibility of exploiting these vesicles for therapeutic purposes is now being investigated.
198 eta-particle-emitting radionuclides used for therapeutic purposes is sufficient to permit external de
199 with utilizing oligodeoxyribonucleotides for therapeutic purposes is their poor delivery into cells c
200 e of tumor-associated antigen (TAA) mRNA for therapeutic purposes is under active investigation.
201 is often added to a number of cell types for therapeutic purposes, it is important from a biomedical
202      Before these cells can be harnessed for therapeutic purposes, it is necessary to understand how
203  Controlling cell functions for research and therapeutic purposes may open new strategies for the tre
204         Targeting specific BMPR subunits for therapeutic purposes may thus provide an approach for ma
205 xample, the expression of a protein used for therapeutic purposes might be triggered by the recogniti
206 se metastatic relapse, stratify patients for therapeutic purposes, monitor response to drugs and ther
207 tibody (mAb) specific to IL13Ralpha2 for the therapeutic purpose of targeting IL13Ralpha2-expressing
208 geting strategy, either may be exploited for therapeutic purposes or may contribute to an unintention
209 rication of phantoms used for diagnostic and therapeutic purposes over a wide range of optical spectr
210  promising molecules have been developed for therapeutic purposes, particularly in the modulators of
211 emisynthetic nanovesicles for diagnostic and therapeutic purposes requires novel approaches to load e
212                                          For therapeutic purposes, selective inhibition of individual
213                      Music has been used for therapeutic purposes since the beginning of cultural his
214 udy enhances the interest of these cells for therapeutic purposes such as AML treatment.
215 trical stimulation of the nervous system for therapeutic purposes, such as deep brain stimulation in
216 onstrated that cell populations intended for therapeutic purposes that are cultured in heterologous a
217  aimed at inhibiting prenylating enzymes for therapeutic purposes, the function of prenylation remain
218 tion in eukaryotic cells and may be used for therapeutic purposes to knock down genes implicated in d
219 ignalling through the downstream pathway for therapeutic purposes under clinically relevant condition
220 ly and reversibly targeting cardiac mRNA for therapeutic purposes using locked nucleic acid-modified
221 ss organ donation once intensive care with a therapeutic purpose was deemed futile and brain death (B
222 -1-targeted disruption of cell signaling for therapeutic purposes was first advanced in 1989 with the
223                                          For therapeutic purposes, we first genetically modified MSCs
224 enerated with weekly stimulation of LCLs for therapeutic purposes were also studied.
225                            Targeting HDL for therapeutic purposes will require understanding its biol
226 t this mechanistic link can be exploited for therapeutic purposes with orally active chemical chapero

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top